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Background: Type 1 diabetes (T1D) is a chronic metabolic condition requiring intensive daily self-care to avoid
both high and low blood glucose levels. Self-care and glycemic outcomes are particularly problematic in
adolescence, a period known for its increased risk of emotional problems. However, the true scope of mood and
anxiety disorders in adolescents with T1D is unknown. Earlier studies are limited by a small sample size, lack of
diagnostic interview data, a focus on depression only, non-adolescent specific estimates, lack of information about
parental emotional problems and/or a cross-sectional design. Diabetes LEAP is a two-year prospective observational
cohort study examining (a) the prevalence and course of depression and anxiety in adolescents with T1D and their
parents/caregivers, (b) the risk factors predicting the presence of these emotional problems, (c) their longitudinal
relation with diabetes outcomes, and (d) the psychosocial care currently in place.
Methods: Adolescents (12–18 years) from 8 Dutch pediatric diabetes clinics are interviewed using the DISC-IV to
establish the presence of mood and anxiety disorders in the previous 4 weeks, the previous 12 months, and
lifetime. They also complete questionnaires, including CDI-2, GAD-7, and PAID-T. Parents/caregivers complete PHQ-
9, GAD-7, and PAID-PR. Follow-up assessments take place after 1 and 2 years.
Discussion: This longitudinal study with diagnostic interviews in a large cohort of adolescents with T1D in the
Netherlands will provide much needed information regarding the prevalence and course of depression and anxiety
in this group, thereby opening avenues for proper recognition, prevention and timely treatment.
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Type 1 diabetes is an increasingly common and serious
health problem
Type 1 diabetes (T1D) is among the most common chronic
conditions in childhood, affecting more than one million
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that the number of young people with T1D will continue to
increase [3, 4]. Having to deal with T1D can be challenging,
not only for the children themselves but also for their fam-
ilies [5]. The Diabetes Control and Complications Trial has
shown the importance of optimal management of blood glu-
cose levels in the prevention of complications [6], but this
can only be achieved with complex daily self-management.
This includes blood glucose monitoring and injecting insulin
multiple times a day or using an insulin pump, while taking
into account factors such as carbohydrate intake and phys-
ical activity.le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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burden
Despite recent advancements in insulin-delivery and
glucose-measurement technologies, glycemic outcomes
remain suboptimal for the majority of young people with
T1D, with less than one third achieving the international
pediatric HbA1c target (< 7.5%/ 58mmol/mol) [7]. This
will be even less when using the new target for children
and adolescents of the International Society for Pediatric
and Adolescent Diabetes (< 7% / 53 mmol/mol) [8]. It is
well known that psychosocial problems are an important
barrier for further improvements in diabetes care [5].
Psychosocial difficulties may interfere with the complex
self-care activities and motivation of young people and
their family, seriously impair diabetes management, and
contribute to suboptimal glycemic outcomes [5]. In turn,
suboptimal HbA1c with concomitant high and fluctuat-
ing glucose values may impact psychosocial functioning.
Thus, proper identification, diagnosis, and treatment of
psychosocial issues and barriers are required to improve
the diabetes care outcomes of young people with T1D.
This is especially relevant for adolescents, as this group
is particularly at risk for suboptimal glycemic outcomes
[9, 10]. Reasons include hormonal changes, a mismatch
between fully developed motor skills and ongoing cogni-
tive maturity, conflicts between diabetes care and devel-
opmental tasks, as well as an increased vulnerability for
the onset or worsening of emotional problems [11–13].
The exact scope of mood and anxiety disorders in
adolescents with T1D is unknown
Having to manage a demanding and rather unpredict-
able condition such as T1D can lead to significant dis-
tress, including feelings of depression and anger, worries
about complications, and negative social interactions
[14]. Young people with T1D also seem to have a 1.5 to
2 times increased risk of psychiatric conditions, includ-
ing mood and anxiety disorders, compared to children
without diabetes [15]. However, the exact size of the
problem in adolescents is still unclear, as the available
studies have several important methodological limita-
tions. Most importantly, the majority of studies have re-
lied on self-report questionnaires to assess symptoms of
depression and anxiety, e.g. [16–18], rather than using a
structured diagnostic interview to determine the pres-
ence of a psychiatric disorder. Much of what self-report
scales assess appears to be (subclinical) diabetes-specific
emotional distress rather than psychopathology [19].
The few studies that have used the diagnostic interview
included less than 100 participants, did not distinguish
between depression and anxiety, combined data from
adolescents with data from children or young adults, or
were conducted 20 years ago when diabetes treatment
options were considerably different [20–25]. A recentPolish study among 207 children aged 8–18 years found
that 4% had a current mood disorder and 16% had a
current anxiety disorder [26]. However, this study might
not be representative of the adolescent T1D population
at large, as it excluded young people with significant co-
existing diseases and did not distinguish estimates for
children and adolescents separately [27].
Information about the course of mood or anxiety
disorders (and related care decisions) is scarce
As the majority of previous studies used a cross-
sectional design, information with respect to the course
of mood or anxiety disorders in adolescents with T1D is
also scarce. Early data from small scale studies suggest
that up to half of all young people with T1D will be con-
fronted with a psychiatric disorder (for example a mood,
anxiety, eating, or conduct disorder) at least once while
growing up [20, 21]. Major depression appeared to be
the most prevalent disorder, affecting approximately 28%
of 92 American youth 10 years after the diagnosis of dia-
betes [21]. In addition, almost one fifth of this sample
developed an anxiety disorder [21]. As a last limitation,
studies that have determined the presence of a mood
and/or anxiety disorder have not systematically assessed
the care decisions that were subsequently taken. A high
quality study is needed, establishing the prevalence and
course of mood and anxiety disorders in a large cohort
of adolescents with T1D, including their link with
diabetes-specific distress, as well as a description of the
treatment and follow-up that is provided.
Parental factors might be a very important, yet
understudied topic
Caring for an adolescent with T1D is challenging, e.g.
due to differences in views on diabetes management and
goals, and poses parents and caregivers at additional risk
for emotional distress [28, 29]. Approximately 20–30%
of parents of children with T1D report clinically signifi-
cant distress, defined as life or parenting stress, anxiety
or depression [29]. In the general population, parental
emotional problems have been associated with increased
risk of internalizing problems (such as anxiety or depres-
sion) in children [30–32]. In the context of T1D, paren-
tal emotional problems may not only have a direct
negative effect on child mental health, but may also
worsen diabetes management and glycemic outcomes
[29, 33]. A continued level of parental involvement in
diabetes care, adjusted to and stimulating the child’s
self-efficacy beliefs, is one of the factors for successful
diabetes outcomes in adolescence [34–37]. Emotional
problems of parents may negatively interfere with their
availability in diabetes care, either by under- or over
involvement [38–41]. Even though parental emotional
distress is common and has been associated with child
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it is infrequently included in (large) studies of children
with T1D. Furthermore, longitudinal data on the course
of these problems are currently lacking and emotional
distress of parents/caregivers is not included as a stand-
ard risk factor in studies examining emotional problems
in children with T1D.
Methods/design
Aim and design
Diabetes LEAP (Longitudinal study of Emotional prob-
lems in Adolescents with type 1 diabetes and their
Parents) was designed as a two-year prospective study to
determine the true scope of depression and anxiety in a
large cohort of adolescents with T1D (12–18 years) and
their parents/caregivers. Its aims are to:
1. Establish the prevalence and course of mood and
anxiety disorders among adolescents with T1D and
of elevated symptoms of depression and anxiety in
parents/caregivers.
2. Describe treatment and follow-up, once the
pediatrician has been informed of the presence of a
mood or anxiety disorder.
3. Identify demographic, clinical and psychological risk
factors associated with the occurrence of emotional
problems in this group.
4. Examine the longitudinal relations of these
problems with diabetes outcomes.
Participants and procedure
Eligible adolescents with type 1 diabetes (12–18 years)
and the parent/caregiver primarily involved in diabetes
care are approached for participation. Exclusion criteria
are diabetes duration of < 6 months, insufficient mastery
of the Dutch language, moderate to severe intellectual
disability, or severe psychosocial circumstances interfer-
ing with participation, all based on medical records and
pediatricians’ judgement. Participants are recruited from
8 pediatric diabetes clinics across the Netherlands,
including the Diabeter clinics (locations: Deventer,
Groningen, Rotterdam, Schiphol, Veldhoven), Albert
Schweitzer hospital Dordrecht, Meander Medical Center
Amersfoort, and Diabetes Centraal (St. Antonius hos-
pital) Utrecht.
Eligible families receive an information package about
study participation, asking them to read the materials
before their next usual care visit. During this visit, the
pediatrician discusses the study with the adolescent and
both of his/her parents. Families who agree to partici-
pate complete written informed consent. Adolescents
can participate (with consent from parents/caregivers),
even if the parent/caregiver him−/herself does not want
to participate. The parent/caregiver cannot participate ifthe adolescent declines. At a subsequent visit, the ado-
lescent undergoes a structured diagnostic interview to
assess the presence and history of mood and anxiety dis-
orders. During the same visit, he/she completes a ques-
tionnaire regarding (potential risk factors for) emotional
problems. Parents/caregivers answer similar question-
naires, either at home or in the clinic. Pediatricians of
the research team then report the presence of disorders
to the adolescent’s pediatrician, who later completes a
questionnaire about the course of action that is taken.
For both adolescents and parents/caregivers, follow-up
assessments take place after 1 and 2 years. Participants
who miss the time window for the one-year follow-up
due to frequent rescheduling are considered as partici-
pants in the two-year follow-up with a missing one-year
follow-up assessment. Participants who decline partici-
pation in the one- year follow-up are asked if they may
be approached for the two-year follow-up. Assessments
are preferably conducted face-to-face; if it is not possible
to schedule a visit, interviews are held over the phone or
via Skype.
The study protocol has been approved for all study
sites by the Medical Ethics Committee of the Máxima
Medical Center (NL48232.015.14). The first participant
was included on 14-1-2015; recruitment and follow-up
assessments are ongoing.
Assessment of depression and anxiety in adolescents
At baseline and 1 and 2 year follow-up, the Dutch ver-
sion of the Diagnostic Interview Schedule for Children
(DISC-IV) [42] is used to establish the presence of mood
and anxiety disorders in adolescents in the previous
4 weeks, in the previous year and during lifetime. The
DISC-IV is a fully-structured diagnostic interview that
can be used by trained lay interviewers to assess mental
disorders based on the definitions of the Diagnostic and
Statistical Manual for Mental Disorders Fourth edition
(DSM-IV). Only the relevant modules of the DISC-IV
are conducted. The introductory module assesses socio-
demographic characteristics and includes the construc-
tion of timelines of the previous year and the whole life
based on life-events. Module A (anxiety disorders) in-
cludes questions about social phobia, separation anxiety,
specific phobia, panic, agoraphobia, generalized anxiety,
selective mutism, obsessive-compulsive behavior and
post-traumatic stress. We added questions assessing fear
of hypoglycemia. Module C (mood disorders) contains
questions about major depression, dysthymia, and
(hypo)mania. At baseline, module L (Whole Life) is also
conducted to assess lifetime prevalence of mood and
anxiety disorders.
When emotional problems are established as being
present in the previous 4 weeks of assessment, we exam-
ine the course of these problems at follow-up. Based on
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olescents are asked to report periods of remission and/
or recurrence if applicable.
At all measurement occasions, adolescents complete
the Children’s Depression Inventory 2 (CDI-2) and the
Generalized Anxiety Disorder 7-item scale (GAD-7)
which assess the self-reported severity of depression and
anxiety symptoms during the previous 2 weeks [43–45].
As an additional indicator of mood problems in the ado-
lescent, the parent report version of the Children’s
Depression Inventory 2 is used [43].
Assessments of depression and anxiety in parents
At all three measurement occasions, parents/care-
givers complete the Patient Health Questionnaire 9-
item scale (PHQ-9) and Generalized Anxiety Disorder
7-item scale (GAD-7) to measure the severity of
depression and anxiety symptoms in the previous
2 weeks [44, 46]. Both measures also have adequate
psychometric properties to identify depression and
anxiety disorders in adults (sensitivity 88 and 89%;
specificity 88 and 82%, respectively) [44, 46].
Assessment of treatment for depression and anxiety
In the case of a positive screening result, the pediatri-
cians of the research team are notified and inform the
doctor caring for the adolescent in question. The de-
scription of treatment and follow-up (once the
pediatrician has been informed of the presence of a
mood or anxiety disorder) include:
- Reason(s) for not making a referral, e.g. watchful
waiting, current treatment, self-reported need for (add-
itional) care, decisions/preferences of adolescent and
his/her family, previous treatment.
- Institution/health care provider to which a referral is
made, waiting list period, treatment provided, decisions/
preferences of adolescent and his/her family.
Assessment of other psychosocial and behavioral
constructs
The Problem Areas in Diabetes Scale teen version
(PAID-T) is used to assess diabetes-specific emotional
distress in adolescents, which concerns negative emo-
tions specifically related to living with diabetes and its
self-management [47]. For parents, the Problem Areas in
Diabetes Scale parent revised version (PAID-PR) is used
[48]. Both adolescents and parents provide their percep-
tion of psychosocial problems during the previous
6 months (Strengths and Difficulties Questionnaire,
SDQ, [49, 50]), following of diabetes care recommenda-
tions in the preceding month (Adherence in Diabetes
Questionnaire, ADQ, [51]), and responsibility for differ-
ent aspects of diabetes care (Diabetes Family Responsi-
bility Questionnaire, DFRQ, [52]).Sociodemographic and clinical data
Medical records provide information regarding the ado-
lescent’s gender, age, most recent weight and height, age
at diabetes diagnosis, diabetes duration, physical/psychi-
atric comorbidities, insulin treatment modality (multiple
daily self-injections or continuous subcutaneous insulin
infusion), lifetime HbA1c (i.e. composite of all HbA1c
values during treatment in the diabetes clinic), the mean
HbA1c in the past year and most recent HbA1c, glucose
measurements and variability around the time of assess-
ment (subsample only), diabetes-related hospitalisations,
severe hypoglycemic events, and occurrence of diabetic
ketoacidosis. Furthermore, the number of clinic visits,
the number of other contacts (e.g. e-mail messages),
cancelled visits, and no shows are extracted from
medical records. Adolescents self-report their current
educational level as part of the DISC-IV and phys-
ical/psychiatric comorbidities by completing a ques-
tionnaire. The questionnaire for parents includes
items about their own gender, age, ethnic back-
ground, education, employment status, marital status,
family socio-economic status, family composition,
relation to the adolescent (e.g. biological parent,
guardian), adolescent life-events, adolescent physical/
psychiatric comorbidities, own history of mood/anx-
iety disorders, and current psychiatric problems in
the family.
An overview of the measures included in diabetes
LEAP is provided in Table 1
Ethical considerations
Informed consent is sought for (1) informing the
pediatrician of study results in the case of a positive
screen, (2) extracting clinical information from the
medical record, and (3) using the data anonymously
for scientific publications. The code of conduct issued
by the national Central Committee on Research
Involving Human Subjects (CCMO) relating to ex-
pressions of objection by minors participating in med-
ical research is followed, as drafted by the Paediatric
Association of The Netherlands (NVK). Adolescents
are invited to enter a draw to win a tablet computer
at each assessment round. Study visits are combined
with usual care visits where possible; extra travel ex-
penses are reimbursed.
Data handling and storage
The handling of personal data complies with the
Dutch Personal Data Protection Act. Families are
assigned a unique study number (unique successive
numbers, starting with 11001). This number is used
as the subject identification code in the anonymous
study data file. The file containing the link between
research codes and specific families is saved on a
Table 1 Concepts and instruments used in Diabetes LEAP
Construct Instrument Baseline 1 year 2 year
Adolescent
4-week (current) mood/anxiety disorder DISC-IV x x x
1-year history mood/anxiety disorder DISC-IV x x x
Lifetime history mood/anxiety disorder DISC-IV x
Severity of depressive symptoms CDI-2 x x x
Severity of anxiety symptoms GAD-7 x x x
Diabetes-specific distress PAID-T x x x
Psychosocial problems SDQ x x x
Following diabetes-care recommendations ADQ self-report x x x
Responsibility diabetes care DFRQ self-report x x x
Care provided mood/anxiety disorder Medical record, doctor x x x
Gender, age, weight, height Medical record x
Highest educational level Medical record, self-report x x x
Diabetes duration, age at diagnosis Medical record x
Lifetime HbA1c Medical record x
Past year and most recent HbA1c Medical record x x x
Glucose measurements/variability (subgroup) Medical record x x x
Physical/psychiatric co-morbidities Medical record, self- & parent-report x x x
Life-events DISC-IV, parent-report x x x
Insulin treatment modality Medical record x x x
Diabetes-related hospitalisations,
severe hypoglycemic events,
occurrence of diabetes ketoacidose
Medical record x x x
Past year number of visits, other
contacts, cancelled visits, no shows
Medical record x x x
Parents/caregivers
Elevated depressive symptoms PHQ-9≥ 10 x x x
Elevated anxiety symptoms GAD-7≥ 10 x x x
Diabetes-specific distress PAID-PR x x x
Adolescent depressive symptoms CDI-2 parent-report x x x
Psychosocial problems SDQ parent-report x x x
Following diabetes-care recommendations ADQ parent-report x x x
Responsibility diabetes care DFRQ parent-report x x x
Adolescent life-events Parent-report x x x
Gender, age, ethnic background,
education, employment status, partner
Self-report x x x
Socio-economic status family Self-report, medical record x x x
Primary diabetes caregiver Self-report, doctor x x x
Relation to child, description family Self-report x x x
Current and history mood/anxiety disorder Self-report x x x
Current psychiatric problems in family Parent-report x x x
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conducting the assessments. Psychology students
assisting in the data collection sign a research con-
tract, based on the Dutch Personal Data ProtectionAct. The anonymized data set is saved on a secure
server. Data will be stored at this server for at least
15 years after the end of the study, in accordance
with Tilburg University regulations.
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Unless otherwise specified, statistical analyses will be per-
formed using IBM SPSS Statistics v24, with significance level
p < 0.05. The prevalence, course and treatment of emotional
problems in adolescents with type 1 diabetes and their par-
ents/caregivers (research aim #1 and #2) is established using
descriptive statistics based on the sample at hand. Other
analyses depend on the specific research questions and will
be reported in detail in the papers concerned. These include
logistic regression analysis (including a check of relevant as-
sumptions) to examine which risk factors are associated
with the occurrence of a mood and/or anxiety disorder (re-
search aim #3) and longitudinal path modelling/structural
equation modelling to examine the longitudinal relation be-
tween emotional problems and diabetes outcomes (research
aim #4). To maximize the available data, the advanced Full
Information Maximum Likelihood method will be applied
to handle missing data. To get a sense of the required sam-
ple size, we posited a conservative logistic regression for the
research question on risk factors for mood/anxiety disorders
over the entire study period. As our study will be the first to
determine the prevalence of these disorders in Dutch ado-
lescents with type 1 diabetes, we calculated a range of sam-
ple sizes based on different cumulative event rates (175 to
400 required participants) [53]. Taking into account statis-
tical restrictions [54], non-response and loss to follow-up,
we have to approach all families from all participating
centers who meet the inclusion criteria and none of the ex-
clusion criteria (n = 831).
Discussion
The proposed prospective observational study will pro-
vide a much needed indication of the prevalence, course,
risk factors and clinical impact of emotional problems
among adolescents with type 1 diabetes and their par-
ents/caregivers, thereby opening avenues for proper rec-
ognition, prevention and timely treatment. This may
alleviate stress on scarce health care resources, making
way for policy adjustments and re-allocation of funds.
Diabetes LEAP will also shed more light on the current
trajectories of psychological care after detection of emo-
tional problems. A better understanding of the decision-
making process will facilitate development and adjustments
towards optimal care. By disentangling psychopathology and
subclinical diabetes-specific distress, we also hope to assist
policy makers in obtaining a better match between the prob-
lems at hand and mental health professionals and interven-
tions. Diabetes LEAP will also provide an important
contribution to the scientific literature, allowing compari-
sons with data from other countries and sharing of lessons
learned.
Some potential limitations must also be acknowledged.
Recruitment and preservation of participants in research
is often challenging, and even more so in the case ofadolescents and sensitive topics [55]. Following previous
recommendations to increase the response rate and re-
duce attrition, e.g. [56], we selected a research team with
knowledge about diabetes and child psychology, involve
paediatricians in the recruitment procedure, collaborate
closely with site personnel, and offer proportional incen-
tives for participation to families. To ensure sufficient
power to conduct the longitudinal analyses, recruitment
takes place in 8 paediatric diabetes clinics. However,
sampling bias may occur if families experiencing emo-
tional problems shy away from participation. Also, indi-
viduals who do not experience any problems might not
feel inclined to participate. In an effort to minimize the
risk of sampling bias and maximize the external validity
of study results, the information package emphasized
that participation in research is voluntary and that every
adolescent/parent contribution is a valuable addition to
the study. In order to limit attrition and support sus-
tained commitment, we send participating families regu-
lar updates through clinic newsletters.
The data from this study will include results from psy-
chiatric diagnostic interviews in a large cohort of adoles-
cents with T1D in the Netherlands. We expect that it
will further strengthen the scientific literature in this
area, as we aim to provide much needed information re-
garding the scope of depression and anxiety in this
group. This will hopefully contribute to better recogni-
tion, prevention and treatment of these problems and
more optimal pediatric diabetes care.
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